COMMUNIQUÉS West-GlobeNewswire

-
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia
18/07/2019 -
Intuitive Announces Second Quarter Earnings
18/07/2019 -
Tonix Pharmaceuticals Announces Closing of Public Offering of Common Stock
18/07/2019 -
Transparency notification
18/07/2019 -
Atara Biotherapeutics Announces Proposed Offering of Common Stock
18/07/2019 -
Oxford Immunotec Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019
18/07/2019 -
ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019
18/07/2019 -
Ascent Industries Announces That Annabeth Rose Joins as Operations Director-Oregon
18/07/2019 -
Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc.
18/07/2019 -
Sales of VuduMobile assets from ATW TECH
18/07/2019 -
Vente des actifs de VuduMobile de ATW TECH
18/07/2019 -
Spring Bank Announces Research Agreement with The National Institute of Allergy and Infectious Diseases to Evaluate HBV Antisense Oligonucleotide Compounds
18/07/2019 -
Rafael Pharmaceuticals Announces Expansion into Israel of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®️ (devimistat) in Combination with Modified FOLFIRINOX as First-Line Treatment for Patients with Metastatic Pancreatic Cancer
18/07/2019 -
Misonix to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8
18/07/2019 -
Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions
18/07/2019 -
First Patient Enrolled in Phase 1b/2 Trial of Lixte Biotechnology’s LB-100 in Low or Intermediate-1 Risk Myelodysplastic Syndrome
18/07/2019 -
eSolutions Celebrates 20th Anniversary with Rebrand
18/07/2019 -
Nemaura Medical Inc. Appoints Chris Avery as Vice President of Global Business Operations to Support Global Commercial Launch of SugarBEAT®
18/07/2019 -
Alphatec Announces Commercial Launch of ALIF IdentiTi™ Porous Titanium Interbody System Implant
18/07/2019
Pages